Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Most Accessed Articles




Diabetes-induced Proteome Changes Throughout Development

, 2019; 19(6): 732-743.

Dina Johar*, Sara M. Ahmed, Samer El. Hayek, Nader Al-Dewik, Eshak I. Bahbah, Nabil H. Omar, Mahmoud Mustafa, Doaa O. Salman, Asmaa Fahmey, Mohamed Mottawea, Rasha A.M. Azouz and Larry Bernstein


DOI: 10.2174/1871530319666190305153810


Hypothyroidism Alters the Uterine Lipid Levels in Pregnant Rabbits and Affects the Fetal Size

, 2019; 19(6): 818-825.

Julia Rodríguez-Castelán, Dafne Zepeda-Pérez, Maribel Méndez-Tepepa, Marlenne Castillo-Romano, Marlen Espíndola-Lozano, Arely Anaya-Hernández, Pere Berbel and Estela Cuevas-Romero*


DOI: 10.2174/1871530318666181102093621









Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.78

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi



Advertisement

Thyroid Awareness MonthNational Glaucoma Awareness Month

Related Journals

Related eBooks

eBooks Catalog